A Safety, Tolerability, and Pharmacokinetic Study of Tucatinib in Healthy Japanese and Caucasian Subjects
Clinical trial NCT03914755 · COMPLETED
Trial details
- NCT number
- NCT03914755
- Sponsor
- Seagen Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-08
- Primary completion
- 2019-08-04
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.